Clear Compliance Labelling: Legitimate vendors clearly label products with their exact mass (12mg) and include explicit language designating the chemical exclusively for laboratory research use
A 2025 letter in Diabetes Care noted that microdose strategies may suit individual circumstances but cannot yet be generalized, and the American Diabetes Association has declined to endorse compounded formulations
In this blog post, we will delve into the current landscape of GLP-1 medications, exploring the implications of recent regulatory changes, the potential impact on patients, and the alternatives that might still be available
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the action of the naturally occurring hormone GLP-1
There can be no assurance that we will have available assets to pay to the holders of common stock, or any amounts, upon such a liquidation, dissolution or winding-up of our Company
"Based on accumulated evidence, it does not seem like GLP-1 drugs when used during the months after conception increase the risk of common (adverse) outcomes substantially
